Effect of Coronavirus Treatment Protocol on Metabolic Factors of Plasma
Phase 2
- Conditions
- COVID-19 pneumonia.COVID-19, virus identifiedU07.1
- Registration Number
- IRCT20151227025726N35
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients with positive PCR test
Patients with moderate to severe pulmonary involvement
Patients with respiratory rate less than or equal to 30 breaths per minute
Patients with percentage of saturated oxygen less than or equal to 94
Exclusion Criteria
Patients with mechanical ventilation
Patients with psychotic disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma concentrations of amino acids, carnitines and acylcarnitine's. Timepoint: On the third day of hospitalization. Method of measurement: Liquid chromatography-Mass spectrometry.
- Secondary Outcome Measures
Name Time Method Adverse drug reaction. Timepoint: At the end of the study. Method of measurement: Medical record.